
Non-Cystic Fibrosis Bronchiectasis (NCFB): The Next Frontier in Respiratory Drug Innovation | Competitive Intelligence
Non-Cystic Fibrosis Bronchiectasis (NCFB) lacks FDA-approved drugs. Innovation is accelerating to meet high unmet needs and redefine chronic lung care. AUSTIN, TX, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- Non-Cystic Fibrosis …